AMGNs Imdelltra slashes lung cancer death risk by 40% in Phase III, extending survival by over five months compared to…
A new month has arrived. Investors now have a fresh opportunity to buy great stocks. Three Motley Fool contributors believe…
Recently, Zacks.com users have been paying close attention to Amgen (AMGN). This makes it worthwhile to examine what the stock…
In this podcast, Motley Fool analyst Tim Beyers and host Ricky Mulvey discuss:
Walmarts response to tariff uncertainty.
Netflixs booming ad business.
How…
The stock market is anything but normal right now. Not even halfway through the year, the broader benchmark S&P 500…
Todays Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), GE Aerospace (GE)…
Investors looking to cash in on the fast-growing market for weight management medicines will naturally turn to the two leaders…
…
New York (www.aktiencheck.de) - Amgen-Aktienanalyse von Guggenheim Securities:
Vamil Divan, Analyst von Guggenheim Securities, nimmt die Bewertung der Aktie von Amgen…
At current levels, we believe AMGN scores above BMY, buoyed by solid fundamentals and recent positive estimate revisions.…
Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AMGEN INC US0311621009 2,38 USD 2,1268 EUR ARTESIAN RESOURCES CORPORATION US0431132085 0,3074 USD 0,2746…
Two of the best things in the investment world are index funds and dividend-paying stocks. So an even better thing,…
J&J, Eli Lilly, Pfizer, Merck, Amgen are included in this Analyst Blog.…
Amgen outlook revised to stable at S&P, debt reduction continues…
Some research has shown that dividend-paying stocks significantly outperformed their non-dividend-paying peers over the past few decades, and that the…
…
If youre looking for blue chip stocks, theres no better place to start than the Dow Jones Industrial Average (DJINDICES:…
AMGN beats first-quarter estimates for earnings and sales. Sales of most of its products, Prolia, Xgeva, Repatha, Blincyto and Evenity…
THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen hat dank einer starken Nachfrage im abgelaufenen Quartal überraschend viel verdient. Der bereinigte…
THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen hat dank einer starken Nachfrage im abgelaufenen Quartal…
THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen hat dank einer starken Nachfrage im abgelaufenen Quartal überraschend viel verdient. Der…
Amgen on Thursday said its first-quarter profit rose 24%, handily exceeding Wall Street expectations, as product sales increased 11% and…
Reliable dividend income from high-quality companies is a great option for investors seeking to ride out stock market turbulence. Biotech…
Its always a good time to buy solid dividend stocks, but considering the challenging economic environment, now might be a…
Amgen to expand Ohio biotech manufacturing plant…
Amgen on Friday announced a $900 million expansion of its Ohio biotech manufacturing facility, becoming the latest in a string…
Amgen (AMGN) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming…
Vertex Pharmaceuticals (NASDAQ: VRTX) had a fine Tuesday on the stock exchange. The biotechs shares closed the day nearly 3%…
When the stock market is highly volatile, many investors flock to assets that offer stability but dismal growth prospects. However,…
Amgen (AMGN) concluded the recent trading session at $273.68, signifying a -1.3% move from its prior days close.…
In the closing of the recent trading day, Amgen (AMGN) stood at $277.29, denoting a -1.89% change from the preceding…
Equities are down this year because of Donald Trumps trade policies. The 47th U.S. president decided to impose steep tariffs…
Die Aktie von Apple hat am Montag zu den drei stärksten Werten im Dow Jones gezählt. Nur Amgen und Travelers…
New York (www.aktiencheck.de) - Rating-Update:
Terence Flynn, Analyst von Morgan Stanley, stuft die Aktie von Amgen Inc. (ISIN: US0311621009, WKN: 867900,…
Switzerland’s Sandoz files antitrust lawsuit against Amgen in US…
In the latest trading session, Amgen (AMGN) closed at $285.92, marking a +1.6% move from the previous day.…
Its time once again to dust off Motley Fool co-founder David Gardners old writings and pull some lessons forward into…
Trotz stabiler Nachfrage hat das Gesundheitswesen wie der Rest des Marktes einen Rückschlag erlitten. Dieser Pharmariese könnte seine Gewinne in…
Die Aktie von Apple stand am Dienstag erneut massiv unter Druck. Mit einem Minus von fünf Prozent war sie noch…
As biotech investors know, companies in the industry can sometimes earn significant returns in relatively short periods, like a year,…
What should investors do when stocks are tanking over the short term? Probably the best answer is to think long…
One factor that keeps some investors away from healthcare stocks is the sectors dearth of generous and reliable dividend payers.…
Amgen (AMGN) concluded the recent trading session at $310.09, signifying a +1.44% move from its prior days close.…
As predicted by many analysts, economists, and investors, the sweeping tariffs announced by the Trump administration on Wednesday decimated the…
The U.S. Food and Drug Administration has approved the expanded use of Amgens drug, Uplizna, to help reduce the risk…
Investors seeking relief from stock market volatility should take a closer look at Bristol Myers Squibb (NYSE: BMY). At the…
Amgen (AMGN) concluded the recent trading session at $311.55, signifying a +1.5% move from its prior days close.…
Dividend investing is an excellent strategy for (at least) two reasons. Companies that can provide consistent payouts generally have robust…
Four of the 30 stocks that make up the Dow Jones Industrial Average represent the healthcare sector. Within that group,…
As ever in the often quick-developing biotech and pharmaceutical sectors on Tuesday, companies posted a mix of positive and negative…